SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 114 filers reported holding SUTRO BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $531,794 | -39.7% | 153,255 | -19.2% | 0.00% | – |
| Q2 2023 | $881,622 | +32.1% | 189,596 | +31.3% | 0.00% | – |
| Q1 2023 | $667,211 | -63.8% | 144,418 | -36.6% | 0.00% | – |
| Q4 2022 | $1,841,650 | +0.1% | 227,927 | -31.3% | 0.00% | – |
| Q3 2022 | $1,840,000 | +6.4% | 331,573 | -0.2% | 0.00% | – |
| Q2 2022 | $1,730,000 | -37.9% | 332,106 | -2.1% | 0.00% | – |
| Q1 2022 | $2,788,000 | +194.7% | 339,186 | +434.2% | 0.00% | – |
| Q4 2021 | $946,000 | +91.9% | 63,497 | +142.9% | 0.00% | – |
| Q3 2021 | $493,000 | -86.3% | 26,143 | -86.5% | 0.00% | – |
| Q2 2021 | $3,592,000 | -79.6% | 193,178 | -75.0% | 0.00% | -100.0% |
| Q1 2021 | $17,596,000 | +515.9% | 773,106 | +487.4% | 0.00% | – |
| Q4 2020 | $2,857,000 | +2673.8% | 131,620 | +1177.2% | 0.00% | – |
| Q3 2020 | $103,000 | +123.9% | 10,305 | +74.8% | 0.00% | – |
| Q2 2020 | $46,000 | +411.1% | 5,895 | +601.0% | 0.00% | – |
| Q1 2020 | $9,000 | -95.4% | 841 | -95.2% | 0.00% | – |
| Q4 2019 | $194,000 | -11.4% | 17,602 | -26.8% | 0.00% | – |
| Q3 2019 | $219,000 | +2333.3% | 24,042 | +2824.8% | 0.00% | – |
| Q2 2019 | $9,000 | -18.2% | 822 | -16.0% | 0.00% | – |
| Q1 2019 | $11,000 | -87.5% | 978 | -90.0% | 0.00% | – |
| Q4 2018 | $88,000 | – | 9,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |